| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.23 | 5e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.006 |